EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long‐Term Outcomes of BK Viremia in Kidney Transplant Recipients

Srijan Tandukar iD, Qufei Wu, Sneha Chandrashekar, Divyash Shah, Chienhui Chiang, Kathryn Couch, Jennifer Trofe iD, Elizabeth M Sonnenberg iD, Peter Abt iD, Mary Ann Lim, Vishnu Potluri iD, Roy Bloom

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Srijan Tandukar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Renal-Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, BK Virus, Viremia, Polyomavirus Infections. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

BK viremia is associated with worse kidney transplant function and de novo donor‐specific antibodies (DSA), but mortality and graft survival are not impacted in the short‐ and intermediate‐term. The long‐term impact of BK viremia remains unclear.

Methods

We performed a single‐center retrospective study on 1058 consecutive kidney or kidney‐pancreas transplant recipients. We classified the cohort based on the presence or absence of BK viremia, BK viral loads, persistence of BK viremia, and pre‐existing or de novo DSA. Outcomes included mortality, graft loss, death‐censored graft survival (DCGS), estimated glomerular filtration rate, biopsy‐proven acute rejection (BPAR), de novo DSA, ureteral stenosis, and genitourinary (GU) malignancies.

Results

Over a median follow‐up period of 9.7 years, there was no difference in graft loss ( p = 0.08) and mortality ( p = 0.56). Time‐varying multivariable analysis showed no difference in DCGS [HR 1.02, (0.91–1.16)]. Compared to never BK viremic patients, patients with BK viremia had similar graft function at 5 and 10 years ( p = 0.09 and 0.65, respectively), rates of GU malignancies (7.0% vs. 5.2%, p = 0.35) and ureteral stenosis (0.8% vs. 0.4%, p = 0.63). Patients with BK viral loads >10 000 copies/mL had a higher risk of de novo DSA [HR 1.71, (1.08–2.68)] and BPAR [HR 2.11, (1.28–3.47)].

Conclusions

BK viremia did not impact mortality, graft loss, kidney function, GU malignancies, and ureteral stenosis over long‐term follow‐up, but BPAR episodes and development of de novo DSA were higher with viral loads >10 000 copies/mL. Strict monitoring protocols and immunosuppression reduction strategies are effective in minimizing the risk associated with BK viremia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationBK VirusViremiaPolyomavirus InfectionsGraft RejectionTumor Virus InfectionsPostoperative ComplicationsKidney Failure, ChronicHumansMaleFemaleRetrospective StudiesMiddle AgedFollow-Up StudiesGraft SurvivalPrognosisRisk FactorsAdultGlomerular Filtration RateKidney Function TestsSurvival RateTransplant RecipientsViral Load

Stichwörter der Autor:innen

BK nephropathyBK virusbiopsy‐proven acute rejectionde novo DSApre‐existing DSA

Autor:innen und Institutionen

  • Renal-Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, USA.
  • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, USA.
  • University of Pennsylvania, Philadelphia, USA.
  • Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, USA.
  • Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, USA.

ORCID-Profile: Srijan Tandukar, Jennifer Trofe, Elizabeth M Sonnenberg, Peter Abt, Vishnu Potluri

Zitieren

APA

Tandukar, S., Wu, Q., Chandrashekar, S., Shah, D., Chiang, C., Couch, K., Trofe, J., Sonnenberg, E. M., Abt, P., Lim, M. A., Potluri, V., & Bloom, R. (2025). Long‐Term Outcomes of BK Viremia in Kidney Transplant Recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.70333

Vancouver

Tandukar S, Wu Q, Chandrashekar S, Shah D, Chiang C, Couch K, et al. Long‐Term Outcomes of BK Viremia in Kidney Transplant Recipients. Clinical Transplantation. 2025. doi:10.1111/ctr.70333

BibTeX
@article{Tandukar2025,
  author = {Tandukar, Srijan and Wu, Qufei and Chandrashekar, Sneha and Shah, Divyash and Chiang, Chienhui and Couch, Kathryn and Trofe, Jennifer and Sonnenberg, Elizabeth M and Abt, Peter and Lim, Mary Ann and Potluri, Vishnu and Bloom, Roy},
  title = {Long‐Term Outcomes of BK Viremia in Kidney Transplant Recipients},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70333}
}
Kostenlos starten →